DDW: SVR rates slump with real world use of sofosbuvir-based HCV regimens

WASHINGTON – Sustained virologic response rates for genotype 1 and 2 patients are lower with sofosbuvir-based hepatitis C virus regimens in routine clinical practice than clinical trials, results...